Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Multiple Sclerosis

23-NEU-3534432-CQD-Hero-1-650×450 (1)

It’s Time for a New Framework for Characterizing Multiple Sclerosis

A focus on biological processes should improve both research and management

22-NEU-3409067_central-vein-sign_650x450

Central Vein Sign on FLAIR* MRI Comparable to CSF Oligoclonal Bands for Diagnosing MS

Initial pilot study findings suggest a potential reduced need for cerebrospinal fluid testing

22-NEU-3294094-CQD-Hero-650×450

Leveraging Telehealth to Provide Comprehensive Multiple Sclerosis Care

NIH grant supports longitudinal study of clinical, cost and patient/clinician experience outcomes

22-NEU-3222062_mesenchymal-stem-cells_650x450

Phase 2 Trial Hints at Promise of Cellular Therapy for Progressive MS

Single-arm, open-label study offers proof of concept for MSC-NTF cells

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

22-NEU-2902059_multiple-sclerosis_650x450

Phase 2 Data Show Vidofludimus Calcium Suppresses MRI Lesions in Relapsing MS With Good Tolerability

Selective DHODH inhibitor designed as a better-tolerated alternative to teriflunomide

22-NEU-2798010-CQD-Hero-650×450

Three Standout Investigations at ACTRIMS 2022

Research avenues to keep an eye on in MS and NMOSD diagnostics and therapeutics

22-NEU-2672858_medical-cannabis_650x450

Multiple Sclerosis and Cannabis Use: Where Do Patients Get Their Information?

Survey suggests need for evidence-based education among patients and providers alike

22-NEU-2651159_Epstein-Barr-virus_650x450

Epstein-Barr Virus and Development of MS: Required, but Not Sufficient

Be careful not to overinterpret a recent important study

21-NEU-2526665_T-cell-activation_650x450

Antibody-Mediated Autoimmune Encephalitis: A Practical Approach to Diagnosis and Management

Objective clinical and radiographic findings are central to optimal outcomes

21-NEU-2489213-breakhrough-infection-650×450
November 12, 2021/COVID-19

Breakthrough COVID-19 in Patients With Multiple Sclerosis: Snapshot From One Data Registry

Unlikely to be severe, infections are associated with anti-CD20 therapies and fingolimod

BackPage 2 of 3Next

Advertisement

Ad